Patents by Inventor Mark Kent Sloan

Mark Kent Sloan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9801545
    Abstract: Methods and systems for providing data communication in medical systems are disclosed.
    Type: Grant
    Filed: July 30, 2015
    Date of Patent: October 31, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Martin J. Fennell, Mark Kent Sloan
  • Publication number: 20170290511
    Abstract: Method and apparatus for providing a data stream generator that generates a data stream associated with a monitored analyte level, and a radio frequency logic portion operatively coupled to the data stream generator, the radio frequency logic portion configured to generate a radio frequency data stream based on the data stream generated from the data stream generator, the radio frequency logic portion further including one or more finite state machines and a plurality of discrete digital logic circuits, the one or more finite state machines configured to control the plurality of digital logic circuits to generate the radio frequency data stream for wireless communication are provided. Systems and kits incorporating the same are also provided.
    Type: Application
    Filed: June 27, 2017
    Publication date: October 12, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Jeffery Mario Sicurello, Hung Dinh, Mark Kent Sloan
  • Publication number: 20170266380
    Abstract: Method and system for providing basal profile modification in insulin therapy for use with infusion devices includes periodically monitoring the analyte levels of a patient for a predetermined period of time in order to determine, based on the monitored analyte levels, an appropriate modification factor to be incorporated into the underlying basal profile which was running at the time the periodic monitoring of the analyte levels were performed.
    Type: Application
    Filed: June 5, 2017
    Publication date: September 21, 2017
    Inventors: Mark Kent Sloan, Gary Alan Hayter
  • Publication number: 20170245760
    Abstract: Methods and systems for providing data communication in medical systems are disclosed.
    Type: Application
    Filed: May 9, 2017
    Publication date: August 31, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Martin J. Fennell, Lei He, Mark Kent Sloan
  • Patent number: 9730584
    Abstract: A glucose measuring system includes a glucose meter that incorporates wireless communication capabilities. The meter can advantageously be a low cost meter by eliminating expensive components, such as the display. The user nevertheless is able to retrieve and view his or her glucose values by referring to displays within the glucose measuring local area network. Feedback via these displays can advantageously be used by the diabetic to create a higher level of confidence and safety.
    Type: Grant
    Filed: February 10, 2014
    Date of Patent: August 15, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Charles L. Nelson, Mark Kent Sloan, Robert Y. Jin, Feng Jiang, Jen-Chyun Chen, Arthur Eugene Anderson, III, Charles T. Liamos
  • Patent number: 9693688
    Abstract: Method and apparatus for providing a data stream generator that generates a data stream associated with a monitored analyte level, and a radio frequency logic portion operatively coupled to the data stream generator, the radio frequency logic portion configured to generate a radio frequency data stream based on the data stream generated from the data stream generator, the radio frequency logic portion further including one or more finite state machines and a plurality of discrete digital logic circuits, the one or more finite state machines configured to control the plurality of digital logic circuits to generate the radio frequency data stream for wireless communication are provided. Systems and kits incorporating the same are also provided.
    Type: Grant
    Filed: July 16, 2015
    Date of Patent: July 4, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Jeffery Mario Sicurello, Hung Dinh, Mark Kent Sloan
  • Patent number: 9669162
    Abstract: Method and system for providing basal profile modification in insulin therapy for use with infusion devices includes periodically monitoring the analyte levels of a patient for a predetermined period of time in order to determine, based on the monitored analyte levels, an appropriate modification factor to be incorporated into the underlying basal profile which was running at the time the periodic monitoring of the analyte levels were performed.
    Type: Grant
    Filed: March 16, 2016
    Date of Patent: June 6, 2017
    Inventors: Mark Kent Sloan, Gary Alan Hayter
  • Patent number: 9649057
    Abstract: Methods and systems for providing data communication in medical systems are disclosed.
    Type: Grant
    Filed: May 11, 2015
    Date of Patent: May 16, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Martin J. Fennell, Lei He, Mark Kent Sloan
  • Patent number: 9625413
    Abstract: Method and apparatus for performing a discrete glucose testing and bolus dosage determination including a glucose meter with bolus calculation function are provided.
    Type: Grant
    Filed: May 19, 2015
    Date of Patent: April 18, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Mark Kent Sloan, R. Curtis Jennewine
  • Publication number: 20170086756
    Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
    Type: Application
    Filed: December 13, 2016
    Publication date: March 30, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
  • Patent number: 9549694
    Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
    Type: Grant
    Filed: November 11, 2015
    Date of Patent: January 24, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
  • Publication number: 20170000426
    Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
    Type: Application
    Filed: September 8, 2016
    Publication date: January 5, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
  • Publication number: 20160213289
    Abstract: Methods and systems for providing data communication in medical systems are disclosed.
    Type: Application
    Filed: April 4, 2016
    Publication date: July 28, 2016
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Martin J. Fennell, Lei He, Mark Kent Sloan
  • Publication number: 20160193410
    Abstract: Method and system for providing basal profile modification in insulin therapy for use with infusion devices includes periodically monitoring the analyte levels of a patient for a predetermined period of time in order to determine, based on the monitored analyte levels, an appropriate modification factor to be incorporated into the underlying basal profile which was running at the time the periodic monitoring of the analyte levels were performed.
    Type: Application
    Filed: March 16, 2016
    Publication date: July 7, 2016
    Inventors: Mark Kent Sloan, Gary Alan Hayter
  • Patent number: 9332944
    Abstract: Method and system for providing a fault tolerant data receiver unit configured with a partitioned or separate processing units, each configured to perform a predetermined and/or specific processing associated with the one or more substantially non-overlapping functions of the data monitoring and management system is provided.
    Type: Grant
    Filed: January 31, 2014
    Date of Patent: May 10, 2016
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Christopher V. Reggiardo, Mark Kent Sloan
  • Publication number: 20160119203
    Abstract: Provided are methods, systems, and apparatus for error detection of bits of a data packet received at a receiver unit by detecting corrupted data bits.
    Type: Application
    Filed: January 4, 2016
    Publication date: April 28, 2016
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Mark Kent Sloan, Martin J. Fennell
  • Patent number: 9323898
    Abstract: Method and system for providing basal profile modification in insulin therapy for use with infusion devices includes periodically monitoring the analyte levels of a patient for a predetermined period of time in order to determine, based on the monitored analyte levels, an appropriate modification factor to be incorporated into the underlying basal profile which was running at the time the periodic monitoring of the analyte levels were performed.
    Type: Grant
    Filed: November 15, 2013
    Date of Patent: April 26, 2016
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Mark Kent Sloan, Gary Alan Hayter
  • Patent number: 9314198
    Abstract: Methods and systems for providing data communication in medical systems are disclosed.
    Type: Grant
    Filed: April 3, 2015
    Date of Patent: April 19, 2016
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Martin J. Fennell, Lei He, Mark Kent Sloan
  • Publication number: 20160081560
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Application
    Filed: December 7, 2015
    Publication date: March 24, 2016
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Mark Kent Sloan, Martin J. Fennell
  • Publication number: 20160058345
    Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
    Type: Application
    Filed: November 11, 2015
    Publication date: March 3, 2016
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman